Department of Molecular Pharmacology, School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, PR China.
Department of Molecular Pharmacology, School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, PR China.
Neuropharmacology. 2014 Feb;77:185-92. doi: 10.1016/j.neuropharm.2013.09.024. Epub 2013 Oct 5.
The α2 adrenoceptor is highly enriched in spinal dorsal horn and involved in descending noradrenergic pain modification. Following peripheral tissue injury, intrathecal application of α2 adrenoceptor agonists effectively alleviates the pathological pain hypersensitivity, although the precise mechanisms are not fully understood. The present study induced inflammatory pain by intraplantar injection of Complete Freund's Adjuvant (CFA), and prepared the spinal cord slices to assay the possible influence of α2 adrenoceptor agonist clonidine on the synaptic transmission mediated by NMDA receptor (NMDAR), a critical player in spinal sensitization. Whole-cell patch clamp recordings in lamina II neurons illustrated that clonidine significantly decreased the amplitudes of NMDAR-mediated monosynaptic responses in inflamed mice through activation of α2A-subtype adrenoceptor. No significant alteration in the paired-pulse ratio before and after clonidine application indicated the postsynaptic origin. Intracellular loading of nonhydrolyzable GDP analog GDP-β-S blocked, whereas direct inhibition of cAMP-dependent protein kinase (PKA) mimicked, the inhibitory effect of clonidine on NMDAR currents, implicating that Gαi protein/PKA signaling was involved in clonidine action. Biochemical analysis in vivo revealed that intrathecal clonidine administration specifically decreased the content of GluN2B subunit-containing NMDAR at synaptosomal membrane fraction, a result associated closely with the alleviation of inflammatory pain. Electrophysiological recordings in vitro further demonstrated that GluN2B receptor-selective inhibitor ifenprodil dramatically reduced NMDAR synaptic responses in inflamed mice and more importantly, occluded the synaptic inhibition produced by clonidine. These data suggested that the noradrenergic suppression of inflammatory pain might involve the blockade of GluN2B receptor-mediated nociceptive transmission in spinal dorsal horn.
α2 肾上腺素受体在脊髓背角中高度丰富,并参与下行去甲肾上腺素能疼痛调节。在外周组织损伤后,鞘内给予 α2 肾上腺素受体激动剂可有效缓解病理性疼痛过敏,尽管确切机制尚不完全清楚。本研究通过足底注射完全弗氏佐剂 (CFA) 诱导炎症性疼痛,并制备脊髓切片,以检测 α2 肾上腺素受体激动剂可乐定对 NMDA 受体 (NMDAR) 介导的突触传递的可能影响,NMDAR 是脊髓敏化的关键参与者。在 II 层神经元中进行全细胞膜片钳记录表明,可乐定通过激活 α2A 亚型肾上腺素受体,显著降低了炎症小鼠中 NMDAR 介导的单突触反应的幅度。可乐定应用前后的成对脉冲比无明显变化表明这种作用发生在突触后。细胞内加载非水解型 GDP 类似物 GDP-β-S 阻断,而直接抑制 cAMP 依赖性蛋白激酶 (PKA) 模拟了可乐定对 NMDAR 电流的抑制作用,表明 Gαi 蛋白/PKA 信号通路参与了可乐定的作用。体内生化分析表明,鞘内给予可乐定可特异性降低突触小体膜部分含有 GluN2B 亚单位的 NMDAR 含量,这与炎症性疼痛的缓解密切相关。体外电生理记录进一步表明,GluN2B 受体选择性抑制剂ifenprodil 显著降低了炎症小鼠中 NMDAR 的突触反应,更重要的是,阻断了可乐定产生的突触抑制作用。这些数据表明,去甲肾上腺素能抑制炎症性疼痛可能涉及阻断脊髓背角中 GluN2B 受体介导的伤害性传递。